WorksAgricultural and Biological Sciences
Arginine metabolism drives tumor immune escape by shaping an immunosuppressive microenvironment
Abstract
The tumor microenvironment evolves through the elimination-equilibrium-escape'' paradigm, yet the quantitative mechanisms by which metabolic reprogramming contributes to immune evasion remain unclear. We develop a mathematical model of tumor-immune interactions to investigate how arginine metabolism shapes an immunosuppressive microenvironment. We establish the positivity and boundedness of solutions and analyze the existence and stability of equilibrium states. The model is calibrated using tumor growth data from three mouse cohorts and reproduces tumor growth patterns under distinct immune conditions. The calibrated model predicts faster tumor growth in immunocompetent mice than in immunodeficient controls, with macrophage dynamics accounting for this difference. It further predicts that arginine administration promotes tumor progression by enhancing macrophage polarization and weakening T cell-mediated tumor control. To account for interindividual heterogeneity, we develop the TVInfABC algorithm to generate a virtual mouse cohort. Moreover, our analysis indicates that tumor-associated macrophages can promote transitions from immunologically hot'' to ``cold'' states. Systematic pharmacodynamic simulations further uncover a synergy between arginine depletion (anti-ARG1) and immune checkpoint blockade (anti-PD-1/PD-L1). These results provide a mathematical basis for studying metabolic-immune interactions and for evaluating mechanism-based combination therapies.